There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

Also, Novozymes Biologicals settles pollution case with the US Department of Justice; EntreMed restructures management team; more...

Company and People Notes: Chiral Technologies Europe Acquires ChromTech; Pharmalot Blogger Ed Silverman Resigns; More...

Michigan State University researchers have discovered a technique for viewing whole cells to gain an understanding of protein inclusion bodies.

NMR Approach May Speed Up Protein-Based Drug Development

Carl Jones is a production manager (scale-up) at Protherics UK.

Aline Denton is a compliance manager at Protherics UK, Blaenwaun, Ffostrasol, Llandysul, Ceredigion, Wales, UK, SA44 5JT, tel. +44 1239 851 122.

The authors examine the challenges of integrating a large-scale chromatography and nanofiltration process for purification of a polyclonal antibody.

Integration of Large-Scale Chromatography with Nanofiltration for an Ovine Polyclonal Product

Editors' Picks of Pharmaceutical Science & Technology Innovations

In the Spotlight February 2009

Michelle Hoffman, editorial director of Pharmaceutical Technology.

The incoming administration has renewed hope for stem cells, but less adequate copycats may follow.

A New Start for New Cells

Brief pharmaceutical news items for January 2009.

Pharma Capsules

The authors describe a novel analytical approach that uses the shape-analysis capabilities of MFI to detect and enumerate silicone oil microdroplets in protein formulations that also contain aggregates of similar size and in a similar concentration.

Silicone Microdroplets in Protein Formulations—Detection and Enumeration

Susan J. Schniepp is a fellow at Regulatory Compliance Associates, Inc. and a member of Pharmaceutical Technology's Editorial Advisory Board.

The USP public-comment process exists for a reason. Industry needs to take advantage. This article contains bonus online-exclusive material.

Insider Solutions: Have a Say in USP Standards

Instead of hampering progress, cost pressures might inspire Big Pharma to get creative.

Will 2009 Bring Innovation?

Also, Crucell and DSM announce deals with GSK, Talecris, and CSL; Nobel Prize winner Luc Montagnier joins Viral Genetics; more...

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes